Delivery Order SPE2DB22D2214-SPE2DB25FS2TX

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2TX
    Delivery Order

This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,981.79 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a critical supplier to federal healthcare programs, particularly within the military and veterans' healthcare systems, Amerisourcebergen plays a significant role in delivering essential pharmaceutical and medical commodities to serve the needs of government beneficiaries.

Generated 2/12/25, 9:04 AM